Clinical Guide

The Enhanced Liver Fibrosis (ELF) Test

The ELF Test is a simple blood test that can assess the risk of disease progression in patients with advanced fibrosis due to nonalcoholic steatohepatitis (NASH).

Download the clinical guide to learn how the ELF Test works, and the clinical value of prognostic testing.

Download the guide to learn how the ELF Test can be integrated into your patient management today.

View our privacy policy

Have a question? Talk to sales.

From the guide What patients are at a higher risk of developing or having NAFLD?

BMI ≥ 30
60-95% also have NAFLD
Heart Disease
69% also have NAFLD
Type 2 Diabetes
50-74% also have NAFLD
50-74% also have NAFLD

2 or more features of metabolic syndrome have a 90% chance of having NAFLD